Hypertension in Response to Chronic Reductions in Uterine Perfusion in Pregnant Rats: Effect of Tumor Necrosis Factor-alpha Blockade

Overview

Journal Hypertension

Date 2008 Nov 5

PMID 18981324

Citations 107

Authors

Babbette LaMarca

Josh Speed

Lillian Fournier

Sara A Babcock

Hunter Berry

Kathy Cockrell

Joey P Granger

Affiliations

Soon will be listed here.

Abstract

Reductions in uterine perfusion pressure (RUPP) in pregnant rats is associated with increased tumor necrosis factor-alpha (TNF-alpha). This study was designed to determine the role of endogenous TNF-alpha in mediating changes in arterial pressure and endothelin-1 (ET-1) in RUPP rats. To achieve this goal we examined the effect of RUPP in the presence and absence of a TNF-alpha-soluble receptor, etanerecept (0.4 mg/kg). Mean arterial pressure increased from 102+/-1 mm Hg in normal pregnant (NP) rats to 134+/-3 mm Hg (P<0.05) in RUPP rats. Serum TNF-alpha increased to 40+/-7.6 pg/mL in RUPP rats (n=24) versus 14.8+/-3.3 pg/mL (n=16; P<0.05) in NP rats. Administration of etanerecept decreased TNF-alpha in RUPP rats (n=20) to 17.2+/-3 pg/mL and mean arterial pressure to 118+/-2 mm Hg (P<0.05). Tissue ET-1 decreased in etanerecept-treated RUPP rats compared with control RUPP rats. The direct effect of TNF-alpha blockade on endothelial activation in response to placental ischemia was examined in human umbilical vein endothelial cells. ET-1 secreted from human umbilical vein endothelial cells treated with RUPP serum was 59.2+16 pg/mg and decreased when etanerecept was added to the medium with RUPP serum (7.60+/-0.77 pg/mg), as well as in response to serum from etanerecept-treated RUPP rats (7.30+/-0.55 pg/mg; P<0.001). ET-1 secreted from human umbilical vein endothelial cells was 15.6+/-2 pg/mg when treated with NP serum. These data support the hypothesis that endogenous TNF-alpha is an important stimulus for ET-1 in response to placental ischemia and is important in mediating endothelial cell activation and hypertension during pregnancy.

Citing Articles

Reduced uterine perfusion pressure as a model for preeclampsia and fetal growth restriction in murine: a systematic review and meta-analysis.

van Kammen C, Taal S, Wever K, Granger J, Lely A, Terstappen F Am J Physiol Heart Circ Physiol. 2024; 327(1):H89-H107.

PMID: 38758122 PMC: 11380978. DOI: 10.1152/ajpheart.00056.2024.

Maternal immune suppression during pregnancy does not prevent abnormal behavior in offspring.

Griffin A, Bowles T, Solis L, Railey T, Beauti S, Robinson R Biol Sex Differ. 2024; 15(1):27.

PMID: 38532505 PMC: 10967052. DOI: 10.1186/s13293-024-00600-8.

Luteolin prevents TNF-α-induced NF-κB activation and ROS production in cultured human placental explants and endothelial cells.

Eddy A, Rajakumar A, Spradley F, Granger J, Rana S Placenta. 2023; 145:65-71.

PMID: 38096686 PMC: 10872317. DOI: 10.1016/j.placenta.2023.12.004.

VASCULAR AND RENAL MECHANISMS OF PREECLAMPSIA.

Wang X, Shields C, Ekperikpe U, Amaral L, Williams J, Cornelius D Curr Opin Physiol. 2023; 33.

PMID: 37009057 PMC: 10062189. DOI: 10.1016/j.cophys.2023.100655.

Setting a stage: Inflammation during preeclampsia and postpartum.

Herrock O, Deer E, LaMarca B Front Physiol. 2023; 14:1130116.

PMID: 36909242 PMC: 9995795. DOI: 10.3389/fphys.2023.1130116.

References

Roberts J, Taylor R, GOLDFIEN A . Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens. 1991; 4(8):700-8. DOI: 10.1093/ajh/4.8.700. View

Fichtlscherer S, Rossig L, Breuer S, Vasa M, Dimmeler S, Zeiher A . Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation. 2001; 104(25):3023-5. DOI: 10.1161/hc5001.101749. View

Minagawa M, Narita J, Tada T, Maruyama S, Shimizu T, Bannai M . Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system. Cell Immunol. 1999; 196(1):1-13. DOI: 10.1006/cimm.1999.1541. View

Arenas I, Armstrong S, Xu Y, Davidge S . Chronic tumor necrosis factor-alpha inhibition enhances NO modulation of vascular function in estrogen-deficient rats. Hypertension. 2005; 46(1):76-81. DOI: 10.1161/01.HYP.0000168925.98963.ef. View

Granger J . Inflammatory cytokines, vascular function, and hypertension. Am J Physiol Regul Integr Comp Physiol. 2004; 286(6):R989-90. DOI: 10.1152/ajpregu.00157.2004. View

Elmarakby A, Quigley J, Imig J, Pollock J, Pollock D . TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2007; 294(1):R76-83. PMC: 2820582. DOI: 10.1152/ajpregu.00466.2007. View

LaMarca B, Bennett W, Alexander B, Cockrell K, Granger J . Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension. 2005; 46(4):1022-5. DOI: 10.1161/01.HYP.0000175476.26719.36. View

Granger J, LaMarca B, Cockrell K, Sedeek M, Balzi C, Chandler D . Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med. 2006; 122:383-92. DOI: 10.1385/1-59259-989-3:381. View

Alexander B, Rinewalt A, Cockrell K, Massey M, Bennett W, Granger J . Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension. 2001; 37(2 Pt 2):485-9. DOI: 10.1161/01.hyp.37.2.485. View

10.

Pober J, COTRAN R . Cytokines and endothelial cell biology. Physiol Rev. 1990; 70(2):427-51. DOI: 10.1152/physrev.1990.70.2.427. View

11.

Khalil R, Granger J . Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol. 2002; 283(1):R29-45. DOI: 10.1152/ajpregu.00762.2001. View

12.

Avunduk M, Avunduk A, Oztekin E, Baltaci A, Ozyazgan Y, Mogolkoc R . Etanercept treatment in the endotoxin-induced uveitis of rats. Exp Eye Res. 2004; 79(3):357-65. DOI: 10.1016/j.exer.2004.06.001. View

13.

Wang P, Ba Z, Chaudry I . Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. Am J Physiol. 1994; 266(6 Pt 2):H2535-41. DOI: 10.1152/ajpheart.1994.266.6.H2535. View

14.

Agirbasli M, Inanc N, Baykan O, Direskeneli H . The effects of TNF alpha inhibition on plasma fibrinolytic balance in patients with chronic inflammatory rheumatical disorders. Clin Exp Rheumatol. 2006; 24(5):580-3. View

15.

Taylor R, Varma M, Teng N, Roberts J . Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab. 1990; 71(6):1675-7. DOI: 10.1210/jcem-71-6-1675. View

16.

Conrad K, Benyo D . Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 1997; 37(3):240-9. DOI: 10.1111/j.1600-0897.1997.tb00222.x. View

17.

Saftlas A, Olson D, Franks A, Atrash H, Pokras R . Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol. 1990; 163(2):460-5. DOI: 10.1016/0002-9378(90)91176-d. View

18.

LaMarca B, Ryan M, Gilbert J, Murphy S, Granger J . Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep. 2008; 9(6):480-5. DOI: 10.1007/s11906-007-0088-1. View

19.

Benyo D, Miles T, Conrad K . Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab. 1997; 82(5):1582-8. DOI: 10.1210/jcem.82.5.3916. View

20.

Roberts L, LaMarca B, Fournier L, Bain J, Cockrell K, Granger J . Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension. 2006; 47(3):615-8. DOI: 10.1161/01.HYP.0000197950.42301.dd. View